BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsieh YY, Tung SY, Lee K, Wu CS, Wei KL, Shen CH, Chang TS, Lin YH. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gastroenterol 2012; 18(8): 746-753 [PMID: 22371634 DOI: 10.3748/wjg.v18.i8.746]
URL: https://www.wjgnet.com/1007-9327/full/v18/i8/746.htm
Number Citing Articles
1
Thomas Pembroke, Giada Sebastiani. Diagnostic Methods for Cirrhosis and Portal Hypertension2018; : 63 doi: 10.1007/978-3-319-72628-1_5
2
Mette J. Nielsen, Konstantin Kazankov, Diana J. Leeming, Morten A. Karsdal, Aleksander Krag, Francisco Barrera, Duncan McLeod, Jacob George, Henning Grønbæk, Matias A Avila. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C PatientsPLOS ONE 2015; 10(9): e0137302 doi: 10.1371/journal.pone.0137302
3
Jing Ma, Yongfang Jiang, Guozhong Gong. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infectionEuropean Journal of Gastroenterology & Hepatology 2013; 25(4): 428 doi: 10.1097/MEG.0b013e32835cb5dd
4
Ayfer BAKIR, Mustafa GÜNEY, Harun ERDAL, Özlem YAVUZ, Armağan GÜNAL, Mustafa GÜLŞEN, Mehmet Tevfik YAVUZ. Assessment of The Performances of Hepatitis C Virus Viral Markers, Age-Platelet Index and Aspartate aminotransferase to Alanine Aminotransferase Ratio Scores, in Predicting Liver HistopathologyTurkish Journal of Internal Medicine 2020;  doi: 10.46310/tjim.825814
5
Banu D. Ozel, Orhan K. Poyrazoğlu, Ahmet Karaman, Hatice Karaman, Engin Altinkaya, Eylem Sevinç, Gökmen Zararsiz. The PAPAS indexEuropean Journal of Gastroenterology & Hepatology 2015; 27(8): 895 doi: 10.1097/MEG.0000000000000379
6
Dalia Omran, Rania A. Zayed, Mohammed M. Nabeel, Lamiaa Mobarak, Zeinab Zakaria, Azza Farid, Mohamed Hassany, Sameh Saif, Muhammad Mostafa, Omar Khalid Saad, Ayman Yosry. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian PatientsViral Immunology 2018; 31(4): 315 doi: 10.1089/vim.2017.0134
7
Pinar Korkmaz, Nese Demirturk, Ayse Batırel, Ahmet Cem Yardimci, Unal Cagir, Salih Atakan Nemli, Fatime Korkmaz, Fusun Zeynep Akcam, Huseyin Sener Barut, Burcu Bayrak, Faruk Karakecili, Huseyin Tarakci, Zerrin Yulugkural, Esma Yuksel, Nazlım Aktug Demir, Onur Ural, Sua Sumer, Rezan Harman, Ayten Kadanali, Sinan Ozturk, Sila Cetin Akhan, Necla Eren Tulek, Derya Keten, Alper Sener, Bilgehan Aygen, Aysel Kocagul Celikbas, Fatma Yilmaz Karadag, Gule Aydin, Eyup Arslan, Cahide Sacligil, Gulfem Akengin Ocal, Alpaslan Tanoglu, Asim Ulcay, Ergenekon Karagoz, Nese Saltoglu, Fatma Sırmatel, Hayrettin Akdeniz, Aynur Aynıoglu, Selcan Arslan Ozel, Selmin Dirgen Caylak, Ilhami Celik, Yesim Alpay, Zehra Bestepe Dursun, Muhammed Bekcibasi, Gunay Tuncer Ertem, Arzu Tigli, Elif Sargin Altunok, Kemal Avsar, Kaya Suer, Murat Sayan. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from TurkeyHepatitis Monthly 2017; (In Press) doi: 10.5812/hepatmon.60266
8
Qing Pang, Jing-Yao Zhang, Xin-Sen Xu, Si-Dong Song, Wei Chen, Yan-Yan Zhou, Run-Chen Miao, Kai Qu, Su-Shun Liu, Ya-Feng Dong, Chang Liu. The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinomaScandinavian Journal of Clinical and Laboratory Investigation 2015; 75(1): 73 doi: 10.3109/00365513.2014.981759
9
Joanna Gorka-Dynysiewicz, Monika Pazgan-Simon, Jolanta Zuwala-Jagiello. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis CBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2639248
10
Barbara J. Turner, Chen-Pin Wang, Trisha V. Melhado, Raudel Bobadilla, Mamta K. Jain, Amit G. Singal. Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic GroupsClinical Gastroenterology and Hepatology 2019; 17(7): 1356 doi: 10.1016/j.cgh.2018.11.059
11
Roberta D’Ambrosio, Elisabetta Degasperi, Alessio Aghemo, Mirella Fraquelli, Pietro Lampertico, Maria Grazia Rumi, Floriana Facchetti, Eleonora Grassi, Giovanni Casazza, William Rosenberg, Pierre Bedossa, Massimo Colombo, Salvatore Petta. Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to InterferonPLOS ONE 2016; 11(6): e0155967 doi: 10.1371/journal.pone.0155967
12
Barbara J. Turner, Yuanyuan Liang, Amit G. Singal. FIB-4 and imaging for measuring fibrosis in hepatitis C virusEuropean Journal of Gastroenterology & Hepatology 2017; 29(2): 192 doi: 10.1097/MEG.0000000000000766
13
Thabata Glenda Fenili Amorim, Guilherme Jönck Staub, César Lazzarotto, André Pacheco Silva, Joice Manes, Maria da Graça Ferronato, Maria Beatriz Cacese Shiozawa, Janaína Luz Narciso-Schiavon, Esther Buzaglo Dantas-Correa, Leonardo de Lucca Schiavon. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis CAnnals of Hepatology 2012; 11(6): 855 doi: 10.1016/S1665-2681(19)31410-3
14
Shelley S Selph, Alexander D Ginsburg, Roger Chou. Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosisSystematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-107
15
Meltem Öznur, Birol Topçu, Aliye Çelikkol. Predictive value of noninvasive indices in chronic hepatitis B virus-related fibrosisEuropean Journal of Gastroenterology & Hepatology 2021; 33(4): 577 doi: 10.1097/MEG.0000000000002045
16
Serpil Erdogan, Halef Okan Dogan, Sevilay Sezer, Sema Uysal, Esra Ozhamam, Serra Kayacetin, Yuksel Koca. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patientsScandinavian Journal of Clinical and Laboratory Investigation 2013; 73(4): 300 doi: 10.3109/00365513.2013.773592
17
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An OverviewAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
18
Ahmet Tarik Eminler, Talat Ayyildiz, Kader Irak, Murat Kiyici, Selim Gurel, Enver Dolar, Macit Gulten, Selim G. Nak. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patientsEuropean Journal of Gastroenterology & Hepatology 2015; 27(12): 1361 doi: 10.1097/MEG.0000000000000468
19
G. Shiha, S. Seif, A. Eldesoky, M. Elbasiony, R. Soliman, A. Metwally, K. Zalata, N. Mikhail. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis CHepatology International 2017; 11(3): 286 doi: 10.1007/s12072-017-9796-z
20
James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich, Andrea D. Branch. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapyLiver International 2014; 34(7): 1018 doi: 10.1111/liv.12342
21
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationHealth Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090